IBRX logo

Immunitybio Inc (IBRX)

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion pr...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
IBRX
ISIN Code
US45256X1037
Currency
US Dollar (USD)
IPO Date
2015-07-28

Contact Information

Company Address
3530 John Hopkins Court, San Diego, CA, United States, 92121
Contact Phone
844 696 5235
Company Website
https://immunitybio.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-30.54%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99